/
MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%

Sector Heatmap

Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%

ACRV — Acrivon Therapeutics, Inc. Common Stock

Nasdaq

Acrivon Therapeutics, Inc. Common Stock

Back to Screener
$2.01
-0.04(-1.95%)
O
2.02
H
2.12
L
2.00
V
315.65K
⏱️ End-of-day dataAs of Oct 1, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Acrivon Therapeutics, Inc. Common Stock Statistics

Total Valuation

Market Cap$89.99M
Enterprise Value$57.19M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding42.85M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ration/a
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earnings-3.00
EV / Salesn/a
EV / EBITDA-2.93
EV / EBIT-2.87
EV / FCF-2.78

Financial Position

Current Ratio8.98
Quick Ration/a
Debt / Equity-0.82
Debt / EBITDA-0.06
Debt / FCF-0.06
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)1241.49%
Return on Assets (ROA)-176.59%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$-250,553
Employee Count76
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+11.05%
50-Day Moving Average$1.92
200-Day Moving Average$1.82
Relative Strength Index (RSI)50.48
Average Volume (20 Days)318,676

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profitn/a
Operating Income-$19.90M
Pretax Income-$19.04M
Net Income-$19.04M
EBITDA-$19.52M
EBIT-$19.90M
Loss Per Share$-0.49

Balance Sheet

Cash & Cash Equivalents$34.06M
Total Debt$1.26M
Net Cash$32.80M
Net Cash Per Share$0.77
Equity (Book Value)-$1.53M
Book Value Per Share$-0.04
Working Capital$88.17M

Cash Flow

Operating Cash Flow-$17.70M
Capital Expenditures-$14.00K
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$20.55M
FCF Per Share$-0.48

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yieldn/a
FCF Yield-22.84%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a